Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Synaptic identifies potent, selective alpha1a-adrenoceptor antagonist

Sep. 25, 1997

RenaGel safely and effectively binds phosphate in volunteers

Sep. 24, 1997

Cytoclonal allowed U.S. patent for PKD treatment

Sep. 23, 1997

Abbott investment to fund lupus drug candidate

Sep. 19, 1997

Efficacy of GAX-65 demonstrated in pediatric study

Sep. 19, 1997

KMD-3213: a newer alpha1-adrenoceptor antagonist for BPH

Sep. 18, 1997

Alpha1-adrenoceptor antagonists improve symptoms of BPO, BPH in clinical studies

Sep. 18, 1997

Gene Logic and Japan Tobacco enter genomic alliance

Sep. 15, 1997

NC-1800 now in phase II development

Sep. 15, 1997

PharmaPrint begins phase II trial of herbal treatment for BPH

Sep. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...